WallStreetZenWallStreetZen

NYSE: ACRE
Ares Commercial Real Estate Corp Stock Forecast, Predictions & Price Target

Analyst price target for ACRE

Based on 4 analysts offering 12 month price targets for Ares Commercial Real Estate Corp.
Min Forecast
$7.00+9.2%
Avg Forecast
$7.38+15.05%
Max Forecast
$8.00+24.8%

Should I buy or sell ACRE stock?

Based on 4 analysts offering ratings for Ares Commercial Real Estate Corp.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
3 analysts 75%
Sell
1 analysts 25%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACRE stock forecasts and price targets.

ACRE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-03-20
lockedlocked$00.00+00.00%2024-03-04

1 of 1

Forecast return on equity

Is ACRE forecast to generate an efficient return?

Forecast return on assets

Is ACRE forecast to generate an efficient return on assets?

ACRE revenue forecast

What is ACRE's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$168.8M+81.65%
Avg 2 year Forecast
$163.0M+75.37%
ACRE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ACRE revenue growth forecast

How is ACRE forecast to perform vs REIT - Mortgage companies and vs the US market?
Company
81.65%
Industry
66.57%
Market
13.58%
ACRE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ACRE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ACRE vs Mortgage REIT Stocks

TickerPricePrice TargetUp/downsideConsensus
ACRE$6.41$7.38+15.05%Hold
NLOP$22.98$60.00+161.10%Buy
IVR$8.09$8.00-1.11%Hold
ORC$8.14N/AN/A
AOMR$11.21$11.00-1.87%Buy

Ares Commercial Real Estate Stock Forecast FAQ

Is Ares Commercial Real Estate Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: ACRE) stock is to Hold ACRE stock.

Out of 4 analysts, 0 (0%) are recommending ACRE as a Strong Buy, 0 (0%) are recommending ACRE as a Buy, 3 (75%) are recommending ACRE as a Hold, 1 (25%) are recommending ACRE as a Sell, and 0 (0%) are recommending ACRE as a Strong Sell.

If you're new to stock investing, here's how to buy Ares Commercial Real Estate stock.

What is ACRE's revenue growth forecast for 2024-2025?

(NYSE: ACRE) Ares Commercial Real Estate's forecast annual revenue growth rate of 81.65% is forecast to beat the US REIT - Mortgage industry's average forecast revenue growth rate of 66.57%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.58%.

Ares Commercial Real Estate's revenue in 2024 is $92,926,000.On average, 2 Wall Street analysts forecast ACRE's revenue for 2024 to be $9,186,537,074, with the lowest ACRE revenue forecast at $8,631,426,422, and the highest ACRE revenue forecast at $9,741,647,727.

In 2025, ACRE is forecast to generate $8,868,709,014 in revenue, with the lowest revenue forecast at $8,718,502,603 and the highest revenue forecast at $9,018,915,426.

What is ACRE's forecast return on assets (ROA) for 2024-2025?

(NYSE: ACRE) forecast ROA is N/A, which is lower than the forecast US REIT - Mortgage industry average of N/A.

What is ACRE's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ACRE price target, the average ACRE price target is $7.38, with the highest ACRE stock price forecast at $8.00 and the lowest ACRE stock price forecast at $7.00.

On average, Wall Street analysts predict that Ares Commercial Real Estate's share price could reach $7.38 by Apr 10, 2025. The average Ares Commercial Real Estate stock price prediction forecasts a potential upside of 15.05% from the current ACRE share price of $6.41.

What is ACRE's forecast return on equity (ROE) for 2024-2025?

(NYSE: ACRE) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.